🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

7 recruiting trials

for Pancreatic Ductal Adenocarcinoma (mPDAC)

Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma NCT06790602Phase 21 site📍 La Jolla University of California, San Diego · Tests: Cemiplimab Plus Gemcitabine Immunoparalysis After Pancreaticoduodenectomy NCT07144917n/a4 sites📍 Lyon📍 Lyon📍 Lyon Hospices Civils de Lyon · Tests: mHLA-DR analysis Hellenic Evaluation of the Long-Term Safety and Efficacy of NalIriFOx as a 1st-line Therapy in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) NCT07723261n/a9 sites📍 Athens📍 Athens📍 Athens Hellenic Cooperative Oncology Group A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients With Newly Diagnosed Metastatic Pancreatic Cancer NCT07701486Phase 1, Phase 21 site📍 Madrid Theriva Biologics SL · Tests: VCN-01 oncolytic adenovirus (zabilugene almadenorepvec), Nab-paclitaxel + Gemcitabine TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC) NCT07284277Phase 1, Phase 25 sites📍 Pamplona📍 Barakaldo📍 Galdakao Clinica Universidad de Navarra, Universidad de Navarra · Tests: TTFields concomitant with modFOLFIRINOX Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) NCT07165951Phase 371 sites📍 Hefei📍 Hefei📍 Beijing Shanghai Chia Tai Tianqing Pharmaceutical Technology Develo… · Tests: TQB2868 Injection, Anlotinib Hydrochloride Capsules, Gemcitabine Hydrochloride Injection, Paclitaxel for Injection, TQB… A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma NCT07481357Phase 13 sites📍 Seongnam📍 Seongnam📍 Seoul Dong-A ST Co., Ltd. · Tests: DA-3501
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy